Christopher A. Marlett, Director at Cue Biopharma, Inc. (CUE), bought 37,042 shares at $4.64 ($172K) on 2018-12-31, disclosed to the SEC on 2019-01-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.64 | 18,521 | $86K | 50.0% |
| 2 | $4.64 | 18,521 | $86K | 50.0% |
| Total | $4.64 avg | 37,042 | $172K | 100% |
| Filing → |
| MDBH | BUY | 2025-10-07 | $14K | — | Filing → |
| MDBH | BUY | 2025-08-29 | $11K | — | Filing → |
| MDBH | BUY | 2025-08-27 | $13K | — | Filing → |